数据表3_林奇综合征患者对用于肠道监测和结直肠癌早期检测的可摄入采样与成像胶囊（Samplecam）的患者接受度：一项焦点小组研究.docx

数据集获取（Figshare）

• 源站标题：Data Sheet 3_Patient acceptability of an ingestible sampling and imaging capsule (Samplecam) for bowel surveillance and early detection of colorectal cancer among Lynch Syndrome patients: a focus group study.docx
• DOI：10.3389/fcacs.2025.1568786.s003
• 发布日期：2025-04-14
• 文件数：1 个
• 文件总体积：118.96 KB
• 源站页面：https://frontiersin.figshare.com/articles/dataset/Data_Sheet_3_Patient_acceptability_of_an_ingestible_sampling_and_imaging_capsule_Samplecam_for_bowel_surveillance_and_early_detection_of_colorectal_cancer_among_Lynch_Syndrome_patients_a_focus_group_study_docx/28786784

命令行下载

curl -L -o "Data Sheet 3_Patient acceptability of an ingestible sampling and imaging capsule (Samplecam) for bowel surveillance and early detection of colorectal .docx" "https://ndownloader.figshare.com/files/53637008"

文件清单

• Data Sheet 3_Patient acceptability of an ingestible sampling and imaging capsule (Samplecam) for bowel surveillance and early detection of colorectal .docx（118.96 KB）

文件总体积 118.96 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

IntroductionLynch syndrome affects an estimated 1 in 279 people in the United Kingdom and presents a high lifetime risk of colorectal cancer. Current strategies to support early diagnosis among Lynch Syndrome patients include surveillance colonoscopy. Capsule endoscopy (CE), which enables visualization of the colon and rectum, is an ingestible imaging device, which could provide a potential means of enabling early detection between colonoscopies. However, current CEs are limited only to visual inspection and are unable to obtain samples from the colon, requiring follow-up colonoscopy for biopsy. To this end, we have been developing a novel ingestible device, which (1) can collect samples from the colon and (2) utilizes artificial intelligence to interpret images obtained (using images collected from colonoscopy and CE conducted with the same cohort). As with any new technology, perceived ease of use and usefulness will be key determinants of implementing ingestible devices within patient care. For this reason, we conducted a focus group study in which people living with Lynch Syndrome were invited to discuss their views on the device.
MethodsOnline focus groups were conducted with adults (aged 18+ years) living with Lynch Syndrome. The focus groups aimed to explore their attitudes toward the use of a novel ingestible sampling and imaging device, for use within the surveillance pathway.
ResultsThree focus groups, comprising 14 participants, were conducted. The majority of participants were of White British ethnicity (n = 13, 92.9%), female (n = 13, 92.9%) and aged 35 years or older (n = 10, 71.4%). We identified 11 barriers and five facilitators to the use of a novel ingestible device. Further, we identified six advantages, one disadvantage, and four potential indications for use. Attitudes were generally positive toward the device. However, participants were clearly opposed to the idea of this replacing colonoscopy entirely. The novel device was seen as something that could be implemented into the surveillance pathway to augment traditional methods and provide additional reassurance during long intervals between procedures.
DiscussionResults were broadly consist

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fcacs.2025.1568786.s003（source: https://frontiersin.figshare.com/articles/dataset/Data_Sheet_3_Patient_acceptability_of_an_ingestible_sampling_and_imaging_capsule_Samplecam_for_bowel_surveillance_and_early_detection_of_colorectal_cancer_among_Lynch_Syndrome_patients_a_focus_group_study_docx/28786784）。